Recently, several researches mentioned that the activation of the autocrine ring of FGF/FGFR, one of the typical RTKs, could act as a compensatory mechanism to promote the survival and growth of EGFR-TKIs resistant lung cancer cells. This evidence concerns the gene EGFR and lung cancer.